LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Sales | 0 | 0 | 85 | 44 | 253 |
| Gross Profit | N/A | N/A | 85 | 44 | 253 |
| Operating Expenses | 26,830 | 23,268 | 25,009 | 21,341 | 15,870 |
| Operating Income | -26,830 | -23,268 | -24,924 | -21,297 | -15,617 |
| Interest Expense | -101 | 0 | 0 | 0 | 0 |
| Other Income | 0 | 28 | 37 | 46 | 51 |
| Pre-tax Income | -26,729 | -23,240 | -24,887 | -21,251 | -15,566 |
| Net Income Continuous | -26,729 | -23,240 | -24,887 | -21,251 | -15,566 |
| Net Income | $-26,729 | $-23,240 | $-24,887 | $-21,251 | $-15,566 |
| EPS Basic Total Ops | -1.21 | -1.26 | -1.45 | -1.23 | -0.90 |
| EPS Basic Continuous Ops | -1.21 | -1.26 | -1.44 | -1.23 | -0.90 |
| EPS Diluted Total Ops | -1.21 | -1.26 | -1.45 | -1.23 | -0.90 |
| EPS Diluted Continuous Ops | -1.21 | -1.26 | -1.44 | -1.23 | -0.90 |
| EBITDA(a) | $-26,530 | $-22,987 | $-24,704 | $-21,097 | $-15,449 |